From laboratory to bedside: a case report of a concise and pragmatic approach on heart failure
DOI:
https://doi.org/10.7175/cmi.v11i2.1301Keywords:
Heart failure, Natriuretic peptides, Laboratory tests, General practice, Multidisciplinary team managementAbstract
Heart failure is one of the most common and intensely studied diseases in the world. Nevertheless, it is considered a difficult condition to diagnose and manage.
This case report, starting from the description of a brief clinical case, aims to directly and concisely explain the most important steps, from laboratory to bedside, in the diagnosis and management of heart failure disease. Physicians can rely on some laboratory tests (e.g., natriuretic peptides) and instrumental exams to diagnose and manage the patients in everyday medical practice. Finally, this article highlights that a multidisciplinary team management can improve the clinical status and the quality of life, thus preventing hospital admission and reducing mortality in patients with heart failure.
References
McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC (HFA). Eur Heart J 2012; 33: 1787-847; https://doi.org/10.1093/eurheartj/ehs104
Mosterd A, Hoes A. Clinical Epidemiology of heart failure. Heart 2007; 93: 1137-46; https://doi.org/10.1136/hrt.2003.025270
Fuat A, Hungin AP, Murphy JJ. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 2003; 326: 196; https://doi.org/10.1136/bmj.326.7382.196
Loehr LR, Rosamond WD, Chang PP, et al. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol 2008; 101: 1016-22; https://doi.org/10.1016/j.amjcard.2007.11.061
Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 1998; 97: 282-9; https://doi.org/10.1161/01.CIR.97.3.282
He J, Ogden LG, Bazzano LA, et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001; 161: 996-1002; https://doi.org/10.1001/archinte.161.7.996
Agusti A, Decramer M, Celli BR, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2017 Report. © Global Initiative for Chronic Obstructive Pulmonary Disease. Available at http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/ (last accessed July 2017)
Ponikowski P, Voors AA, Anker SD, et al. Authors/Task Force Members, Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC), Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016; 18: 891-975; https://doi.org/10.1002/ejhf.592
Jessup M, Brozena S. Heart failure. N Engl J Med 2003; 348: 2007-18; https://doi.org/10.1056/NEJMra021498; https://doi.org/10.1056/NEJMe030030
Mant J, Doust J, Roalfe A, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess 2009; 13: 1-207; https://doi.org/10.3310/hta13320
Williams RP, Oakeshott P. Diagnosis and management of chronic heart failure. BMJ 2014; 348: 1429; https://doi.org/10.1136/bmj.g1429
Omland T, Hagve TA. Natriuretic peptides: physiologic and analytic considerations. Heart Fail Clin 2009; 5: 471-87; https://doi.org/10.1016/j.hfc.2009.04.005
Maisel A, Mueller C, Adams K, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008; 10: 824-39; https://doi.org/10.1016/j.ejheart.2008.07.014
Zaphiriou A, Robb S, Murray-Thomas T, et al. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail 2005; 7: 537-41; https://doi.org/10.1016/j.ejheart.2005.01.022
Lainchbury JG, Troughton RW, Strangman KM, et al. NTerminal Pro-B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death) trial. J Am Coll Cardiol 2009; 55: 53-60; https://doi.org/10.1016/j.jacc.2009.02.095
Khunti K, Squire I, Abrams KR, et al. Accuracy of a 12-lead electrocardiogram in screening patients with suspected heart failure for open access echocardiography: a systematic review and meta-analysis. Eur J Heart Fail 2004; 6: 571-6; https://doi.org/10.1016/j.ejheart.2004.03.013
Thomas JT, Kelly RF, Thomas SJ, et al. Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med 2002; 112: 437-45; https://doi.org/10.1016/S0002-9343(02)01048-3
McMurray JV. Systolic Heart Failure. N Engl J Med 2010; 362: 228-38; https://doi.org/10.1056/NEJMcp0909392
Kotecha T, Fox K. Investigating suspected heart failure. BMJ 2013; 346: 2442; https://doi.org/10.1136/bmj.f2442
Bhala N, Emberson J, Mehri A, et al. Coxib and traditional NSAID Trialists’ Collaboration, Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013; 382: 769-79; https://doi.org/10.1016/S0140-6736(13)60900-9
Ungprasert P, Patompong N, Kittanamongkolchai W. Non-steroidal anti-inflammatory drugs and risk of heart failure exacerbation: A systematic review and meta-analysis. Eur J Intern Med 2015; 26: 685-90; https://doi.org/10.1016/j.ejim.2015.03.008; https://doi.org/10.1016/j.ejim.2015.09.012
Faris R, Flather M, Purcell H, et al. Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol 2002; 82: 149-58; https://doi.org/10.1016/S0167-5273(01)00600-3
Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273: 1450-6; https://doi.org/10.1001/jama.1995.03520420066040; https://doi.org/10.1001/jama.273.18.1450
Granger CB, McMurray JJV, Yusuf S, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 2003; 362: 772-6; https://doi.org/10.1016/S0140-6736(03)14284-5
CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13; https://doi.org/10.1016/S0140-6736(98)11181-9
Jondeau G, Neuder Y, Eicher JC, et al. B-CONVINCED: Beta-blocker CONtinuation Vs INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode. Eur Heart J 2009; 30: 2186-92; https://doi.org/10.1093/eurheartj/ehp323
Campo G, Pavasini R, Biscaglia S, et al. Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease. Eur Heart J Cardiovasc Pharmacother 2015; 1: 205-11; https://doi.org/10.1093/ehjcvp/pvv019
McMurray JJV, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014; 371: 993-1004; https://doi.org/10.1056/NEJMoa1409077
Rutten FH, Clark AL, Hoes AW. How big a problem is heart failure with a normal ejection fraction? BMJ 2016; 352: i1706; https://doi.org/10.1136/bmj.i1706
Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009; 360: 1418-28; https://doi.org/10.1056/NEJMsa0803563
Miró Ò, Peacock FW, McMurray JJ, et al. European Society of Cardiology - Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department. Eur Heart J Acute Cardiovasc Care 2017; 6: 311-20; https://doi.org/10.1177/2048872616633853
Cleland JG, Abraham WT, Linde C, et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J 2013; 34: 3547-56; https://doi.org/10.1093/eurheartj/eht290
Kajimoto K, Sato N, Takano T; investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) registry. Association of anemia and renal dysfunction with in-hospital mortality among patients hospitalized for acute heart failure syndromes with preserved or reduced ejection fraction. Eur Heart J Acute Cardiovasc Care 2016; 5: 89-99; https://doi.org/10.1177/2048872615593387
Dharmarajan K, Hsieh AF, Lin Z, et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA 2013; 309: 355-63; https://doi.org/10.1001/jama.2012.216476
Gheorghiade M, Vaduganathan M, Fonarow GC, et al. Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol 2013; 61: 391-403; https://doi.org/10.1016/j.jacc.2012.09.038
Feltner C, Jones CD, Cenè CW, et al. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Intern Med 2014; 160: 774-84; https://doi.org/10.7326/M14-0083
Chinaglia A, Gaschino G, Asteggiano R, et al. Impact of a nurse-based heart failure management program on hospitalization rate, functional status, quality of life, and medical cost. Ital Heart J 2002; 3: 532-8
Lainscak M, Blue L, Clark AL, et al. Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2011; 13: 115-26; https://doi.org/10.1093/eurjhf/hfq219
Sueta CA, Rodgers JE, Chang PP, et al. Medication adherence based on part D claims for patients with heart failure after hospitalization (from the Atherosclerosis Risk in Communities Study). Am J Cardiol 2015; 116: 413-9; https://doi.org/10.1016/j.amjcard.2015.04.058
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial 4.0 Licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)